High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment

Author： Urbańska-ryś Halina   Robak Tadeusz  

Publisher： Informa Healthcare

ISSN： 1466-1861

Source： Mediators of Inflammation, Vol.12, Iss.4, 2003-08, pp. : 229-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Racial/ethnic disparities in inflammatory gene single‐nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1138-1146

John Wiley & Sons Inc

Access to resources Recommend Favorite

Severe Epidermal Necrolysis after Bortezomib Treatment for Multiple Myeloma

By  

Acta Haematologica, Vol. 118, Iss. 2, 2007-05 ,pp. : 65-67

Karger

Access to resources Recommend Favorite

Molecular and Clinical Follow-Up after Treatment of Multiple Myeloma

By  

Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. : 105-110

Karger

Access to resources Recommend Favorite

Clinical Value of Serum 5-HT Level in Diagnosis and Treatment of Premature Ejaculation

By  

Urologia Internationalis, Vol. 90, Iss. 2, 2012-11 ,pp. : 214-218

Karger

Access to resources Recommend Favorite

The Value of Ifosfamide in the Treatment of Multiple Myeloma

By  

Oncology Research and Treatment, Vol. 21, Iss. 2, 1998-06 ,pp. : 30-33

Karger

Access to resources Recommend Favorite